Free Trial

Motus GI (MOTS) Competitors

Motus GI logo
$0.0004 0.00 (0.00%)
(As of 11/13/2024 ET)

MOTS vs. NMRD, BRSH, DRTSW, ANZUW, BBLGW, BRSHW, GMVDW, HSCSW, BEATW, and LUCYW

Should you be buying Motus GI stock or one of its competitors? The main competitors of Motus GI include Nemaura Medical (NMRD), Bruush Oral Care (BRSH), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), G Medical Innovations (GMVDW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), and Innovative Eyewear (LUCYW). These companies are all part of the "medical equipment" industry.

Motus GI vs.

Motus GI (NASDAQ:MOTS) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends, media sentiment and community ranking.

Nemaura Medical has a net margin of 0.00% compared to Motus GI's net margin of -3,239.75%. Nemaura Medical's return on equity of 0.00% beat Motus GI's return on equity.

Company Net Margins Return on Equity Return on Assets
Motus GI-3,239.75% -1,731.08% -115.99%
Nemaura Medical N/A N/A N/A

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Nemaura Medical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Nemaura Medical Neutral

20.1% of Motus GI shares are held by institutional investors. Comparatively, 4.4% of Nemaura Medical shares are held by institutional investors. 0.3% of Motus GI shares are held by company insiders. Comparatively, 40.4% of Nemaura Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Motus GI received 159 more outperform votes than Nemaura Medical when rated by MarketBeat users. Likewise, 65.73% of users gave Motus GI an outperform vote while only 57.14% of users gave Nemaura Medical an outperform vote.

CompanyUnderperformOutperform
Motus GIOutperform Votes
163
65.73%
Underperform Votes
85
34.27%
Nemaura MedicalOutperform Votes
4
57.14%
Underperform Votes
3
42.86%

Motus GI has a beta of 1.93, suggesting that its share price is 93% more volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.09, suggesting that its share price is 91% less volatile than the S&P 500.

Motus GI has higher revenue and earnings than Nemaura Medical. Nemaura Medical is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$320K0.01-$12.87M-$15.640.00
Nemaura Medical$80K0.10-$14.14M-$0.390.00

Summary

Motus GI beats Nemaura Medical on 7 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MOTS vs. The Competition

MetricMotus GISurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$2,000.00$4.63B$5.33B$8.91B
Dividend YieldN/A39.52%4.98%4.03%
P/E Ratio0.0025.10135.4417.46
Price / Sales0.0163.901,266.8895.47
Price / CashN/A52.4438.8936.42
Price / Book0.005.596.315.92
Net Income-$12.87M$13.58M$118.33M$224.86M
7 Day PerformanceN/A-1.04%-1.43%-0.38%
1 Month PerformanceN/A6.33%3.12%4.21%
1 Year PerformanceN/A55.17%36.57%27.31%

Motus GI Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MOTS
Motus GI
N/A$0.00
flat
N/A-100.0%$2,000.00$320,000.000.0030
NMRD
Nemaura Medical
N/A$0.00
flat
N/AN/A$8,000.00$3,017.000.0040
BRSH
Bruush Oral Care
N/A$0.00
flat
N/A-99.3%$1,000.00$2.92M0.0011Gap Up
DRTSW
Alpha Tau Medical
N/A$0.20
flat
N/AN/A$0.00N/A0.0080News Coverage
ANZUW
Anzu Special Acquisition Corp I
N/A$0.09
flat
N/AN/A$0.00N/A0.002
BBLGW
Bone Biologics
N/A$31.78
flat
N/A+641.9%$0.00N/A0.002Positive News
Gap Down
BRSHW
Bruush Oral Care
N/A$0.01
flat
N/AN/A$0.00$2.92M0.0011
GMVDW
G Medical Innovations
N/A$0.02
flat
N/AN/A$0.00$4.42M0.0072News Coverage
HSCSW
Heart Test Laboratories
N/A$0.03
flat
N/AN/A$0.00$18,600.000.0010Positive News
BEATW
HeartBeam
N/A$0.75
flat
N/A+376.5%$0.00N/A0.005Short Interest ↑
Gap Down
LUCYW
Innovative Eyewear
N/A$0.05
+9.1%
N/A-69.5%$0.00$1.53M0.009Short Interest ↑

Related Companies and Tools


This page (NASDAQ:MOTS) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners